nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorambucil—Alkylating Activity—Mitomycin—urinary bladder cancer	0.232	0.569	CiPCiCtD
Chlorambucil—testicular cancer—urinary bladder cancer	0.214	1	CtDrD
Chlorambucil—Alkylating Activity—Thiotepa—urinary bladder cancer	0.176	0.431	CiPCiCtD
Chlorambucil—GSTP1—urinary bladder cancer	0.164	1	CbGaD
Chlorambucil—GSTP1—Carboplatin—urinary bladder cancer	0.0566	0.354	CbGbCtD
Chlorambucil—GSTP1—Cisplatin—urinary bladder cancer	0.0484	0.302	CbGbCtD
Chlorambucil—GSTP1—Etoposide—urinary bladder cancer	0.0475	0.297	CbGbCtD
Chlorambucil—SLCO1A2—Methotrexate—urinary bladder cancer	0.0076	0.0475	CbGbCtD
Chlorambucil—GSTP1—urine—urinary bladder cancer	0.00172	0.297	CbGeAlD
Chlorambucil—GSTP1—Glutathione conjugation—GSTZ1—urinary bladder cancer	0.00118	0.0919	CbGpPWpGaD
Chlorambucil—GSTP1—Glutathione conjugation—GSTO2—urinary bladder cancer	0.00112	0.0871	CbGpPWpGaD
Chlorambucil—GSTP1—prostate gland—urinary bladder cancer	0.000617	0.107	CbGeAlD
Chlorambucil—GSTP1—Phase II conjugation—GSTZ1—urinary bladder cancer	0.000524	0.0409	CbGpPWpGaD
Chlorambucil—GSTP1—seminal vesicle—urinary bladder cancer	0.000522	0.0903	CbGeAlD
Chlorambucil—GSTP1—Phase II conjugation—GSTO2—urinary bladder cancer	0.000497	0.0388	CbGpPWpGaD
Chlorambucil—GSTP1—Phase II conjugation—NAT1—urinary bladder cancer	0.000497	0.0388	CbGpPWpGaD
Chlorambucil—GSTP1—Glutathione conjugation—HPGDS—urinary bladder cancer	0.000489	0.0381	CbGpPWpGaD
Chlorambucil—GSTP1—Glutathione conjugation—GSTT1—urinary bladder cancer	0.000474	0.037	CbGpPWpGaD
Chlorambucil—GSTP1—Phase II conjugation—UGT2B7—urinary bladder cancer	0.000455	0.0355	CbGpPWpGaD
Chlorambucil—GSTP1—epithelium—urinary bladder cancer	0.000453	0.0784	CbGeAlD
Chlorambucil—GSTP1—smooth muscle tissue—urinary bladder cancer	0.000437	0.0756	CbGeAlD
Chlorambucil—GSTP1—renal system—urinary bladder cancer	0.00042	0.0727	CbGeAlD
Chlorambucil—GSTP1—urethra—urinary bladder cancer	0.000413	0.0714	CbGeAlD
Chlorambucil—SLCO1A2—renal system—urinary bladder cancer	0.000362	0.0627	CbGeAlD
Chlorambucil—GSTP1—Detoxification of Reactive Oxygen Species—SOD2—urinary bladder cancer	0.000347	0.0271	CbGpPWpGaD
Chlorambucil—GSTP1—female reproductive system—urinary bladder cancer	0.000337	0.0583	CbGeAlD
Chlorambucil—GSTP1—Detoxification of Reactive Oxygen Species—GPX1—urinary bladder cancer	0.000331	0.0259	CbGpPWpGaD
Chlorambucil—GSTP1—Biological oxidations—GSTZ1—urinary bladder cancer	0.000307	0.0239	CbGpPWpGaD
Chlorambucil—GSTP1—vagina—urinary bladder cancer	0.000304	0.0527	CbGeAlD
Chlorambucil—GSTP1—NRF2 pathway—UGT2B7—urinary bladder cancer	0.000303	0.0236	CbGpPWpGaD
Chlorambucil—GSTP1—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000302	0.0236	CbGpPWpGaD
Chlorambucil—GSTP1—Glutathione conjugation—GSTM1—urinary bladder cancer	0.000302	0.0236	CbGpPWpGaD
Chlorambucil—GSTP1—Biological oxidations—GSTO2—urinary bladder cancer	0.000291	0.0227	CbGpPWpGaD
Chlorambucil—GSTP1—Biological oxidations—NAT1—urinary bladder cancer	0.000291	0.0227	CbGpPWpGaD
Chlorambucil—GSTP1—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000287	0.0224	CbGpPWpGaD
Chlorambucil—GSTP1—Phase II conjugation—NAT2—urinary bladder cancer	0.000272	0.0212	CbGpPWpGaD
Chlorambucil—GSTP1—Biological oxidations—UGT2B7—urinary bladder cancer	0.000266	0.0207	CbGpPWpGaD
Chlorambucil—GSTP1—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000262	0.0205	CbGpPWpGaD
Chlorambucil—GSTP1—Biological oxidations—CYP4B1—urinary bladder cancer	0.000239	0.0187	CbGpPWpGaD
Chlorambucil—GSTP1—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000236	0.0184	CbGpPWpGaD
Chlorambucil—GSTP1—Phase II conjugation—HPGDS—urinary bladder cancer	0.000218	0.017	CbGpPWpGaD
Chlorambucil—GSTP1—Phase II conjugation—GSTT1—urinary bladder cancer	0.000211	0.0165	CbGpPWpGaD
Chlorambucil—GSTP1—lymph node—urinary bladder cancer	0.000197	0.0341	CbGeAlD
Chlorambucil—GSTP1—Biological oxidations—NAT2—urinary bladder cancer	0.000159	0.0124	CbGpPWpGaD
Chlorambucil—GSTP1—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000157	0.0123	CbGpPWpGaD
Chlorambucil—GSTP1—Cellular responses to stress—VHL—urinary bladder cancer	0.000149	0.0116	CbGpPWpGaD
Chlorambucil—GSTP1—Phase II conjugation—GSTM1—urinary bladder cancer	0.000134	0.0105	CbGpPWpGaD
Chlorambucil—GSTP1—Biological oxidations—HPGDS—urinary bladder cancer	0.000127	0.00993	CbGpPWpGaD
Chlorambucil—GSTP1—Biological oxidations—GSTT1—urinary bladder cancer	0.000124	0.00963	CbGpPWpGaD
Chlorambucil—GSTP1—NRF2 pathway—NQO1—urinary bladder cancer	0.000117	0.00913	CbGpPWpGaD
Chlorambucil—SLCO1A2—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000112	0.00877	CbGpPWpGaD
Chlorambucil—GSTP1—NRF2 pathway—GSTM1—urinary bladder cancer	8.97e-05	0.007	CbGpPWpGaD
Chlorambucil—GSTP1—Cellular responses to stress—RBX1—urinary bladder cancer	8.57e-05	0.00668	CbGpPWpGaD
Chlorambucil—GSTP1—Biological oxidations—GSTM1—urinary bladder cancer	7.87e-05	0.00614	CbGpPWpGaD
Chlorambucil—GSTP1—Metapathway biotransformation—GSTM1—urinary bladder cancer	7.76e-05	0.00605	CbGpPWpGaD
Chlorambucil—Neuropathy peripheral—Fluorouracil—urinary bladder cancer	7.15e-05	0.00201	CcSEcCtD
Chlorambucil—Vomiting—Mitomycin—urinary bladder cancer	7.11e-05	0.002	CcSEcCtD
Chlorambucil—Stomatitis—Fluorouracil—urinary bladder cancer	7.11e-05	0.002	CcSEcCtD
Chlorambucil—Alopecia—Thiotepa—urinary bladder cancer	6.99e-05	0.00197	CcSEcCtD
Chlorambucil—Blood uric acid increased—Methotrexate—urinary bladder cancer	6.9e-05	0.00194	CcSEcCtD
Chlorambucil—Neoplasm malignant—Doxorubicin—urinary bladder cancer	6.88e-05	0.00193	CcSEcCtD
Chlorambucil—Hyperuricaemia—Epirubicin—urinary bladder cancer	6.84e-05	0.00192	CcSEcCtD
Chlorambucil—Neuropathy peripheral—Cisplatin—urinary bladder cancer	6.78e-05	0.0019	CcSEcCtD
Chlorambucil—Dyskinesia—Epirubicin—urinary bladder cancer	6.75e-05	0.0019	CcSEcCtD
Chlorambucil—Pancytopenia—Etoposide—urinary bladder cancer	6.74e-05	0.0019	CcSEcCtD
Chlorambucil—Stomatitis—Cisplatin—urinary bladder cancer	6.74e-05	0.00189	CcSEcCtD
Chlorambucil—Amenorrhoea—Doxorubicin—urinary bladder cancer	6.68e-05	0.00188	CcSEcCtD
Chlorambucil—Neutropenia—Etoposide—urinary bladder cancer	6.64e-05	0.00187	CcSEcCtD
Chlorambucil—Nausea—Mitomycin—urinary bladder cancer	6.64e-05	0.00187	CcSEcCtD
Chlorambucil—Cystitis noninfective—Methotrexate—urinary bladder cancer	6.62e-05	0.00186	CcSEcCtD
Chlorambucil—Cystitis—Methotrexate—urinary bladder cancer	6.55e-05	0.00184	CcSEcCtD
Chlorambucil—Blood uric acid increased—Epirubicin—urinary bladder cancer	6.46e-05	0.00182	CcSEcCtD
Chlorambucil—Pneumonia—Etoposide—urinary bladder cancer	6.37e-05	0.00179	CcSEcCtD
Chlorambucil—Anaemia—Thiotepa—urinary bladder cancer	6.37e-05	0.00179	CcSEcCtD
Chlorambucil—Agitation—Thiotepa—urinary bladder cancer	6.33e-05	0.00178	CcSEcCtD
Chlorambucil—Hyperuricaemia—Doxorubicin—urinary bladder cancer	6.33e-05	0.00178	CcSEcCtD
Chlorambucil—Erythema multiforme—Gemcitabine—urinary bladder cancer	6.29e-05	0.00177	CcSEcCtD
Chlorambucil—Stevens-Johnson syndrome—Etoposide—urinary bladder cancer	6.28e-05	0.00176	CcSEcCtD
Chlorambucil—Dyskinesia—Doxorubicin—urinary bladder cancer	6.25e-05	0.00176	CcSEcCtD
Chlorambucil—Neuropathy peripheral—Etoposide—urinary bladder cancer	6.21e-05	0.00174	CcSEcCtD
Chlorambucil—Cystitis noninfective—Epirubicin—urinary bladder cancer	6.2e-05	0.00174	CcSEcCtD
Chlorambucil—Jaundice—Etoposide—urinary bladder cancer	6.17e-05	0.00174	CcSEcCtD
Chlorambucil—Stomatitis—Etoposide—urinary bladder cancer	6.17e-05	0.00174	CcSEcCtD
Chlorambucil—Leukopenia—Thiotepa—urinary bladder cancer	6.17e-05	0.00173	CcSEcCtD
Chlorambucil—Neoplasm—Methotrexate—urinary bladder cancer	6.13e-05	0.00172	CcSEcCtD
Chlorambucil—Bladder pain—Methotrexate—urinary bladder cancer	6.13e-05	0.00172	CcSEcCtD
Chlorambucil—Mouth ulceration—Methotrexate—urinary bladder cancer	6.13e-05	0.00172	CcSEcCtD
Chlorambucil—Cystitis—Epirubicin—urinary bladder cancer	6.13e-05	0.00172	CcSEcCtD
Chlorambucil—Blood uric acid increased—Doxorubicin—urinary bladder cancer	5.98e-05	0.00168	CcSEcCtD
Chlorambucil—Convulsion—Thiotepa—urinary bladder cancer	5.97e-05	0.00168	CcSEcCtD
Chlorambucil—Alopecia—Gemcitabine—urinary bladder cancer	5.88e-05	0.00165	CcSEcCtD
Chlorambucil—Alopecia—Fluorouracil—urinary bladder cancer	5.78e-05	0.00163	CcSEcCtD
Chlorambucil—Lymphadenopathy—Methotrexate—urinary bladder cancer	5.77e-05	0.00162	CcSEcCtD
Chlorambucil—GSTP1—Cellular responses to stress—CCNE1—urinary bladder cancer	5.75e-05	0.00449	CbGpPWpGaD
Chlorambucil—Bladder pain—Epirubicin—urinary bladder cancer	5.74e-05	0.00161	CcSEcCtD
Chlorambucil—Neoplasm—Epirubicin—urinary bladder cancer	5.74e-05	0.00161	CcSEcCtD
Chlorambucil—Mouth ulceration—Epirubicin—urinary bladder cancer	5.74e-05	0.00161	CcSEcCtD
Chlorambucil—Cystitis noninfective—Doxorubicin—urinary bladder cancer	5.73e-05	0.00161	CcSEcCtD
Chlorambucil—SLCO1A2—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	5.71e-05	0.00445	CbGpPWpGaD
Chlorambucil—Cystitis—Doxorubicin—urinary bladder cancer	5.67e-05	0.00159	CcSEcCtD
Chlorambucil—Confusional state—Thiotepa—urinary bladder cancer	5.67e-05	0.00159	CcSEcCtD
Chlorambucil—GSTP1—Cellular responses to stress—SOD2—urinary bladder cancer	5.61e-05	0.00437	CbGpPWpGaD
Chlorambucil—Infection—Thiotepa—urinary bladder cancer	5.59e-05	0.00157	CcSEcCtD
Chlorambucil—Thrombocytopenia—Thiotepa—urinary bladder cancer	5.5e-05	0.00155	CcSEcCtD
Chlorambucil—Alopecia—Cisplatin—urinary bladder cancer	5.48e-05	0.00154	CcSEcCtD
Chlorambucil—Lymphadenopathy—Epirubicin—urinary bladder cancer	5.4e-05	0.00152	CcSEcCtD
Chlorambucil—Erythema multiforme—Etoposide—urinary bladder cancer	5.37e-05	0.00151	CcSEcCtD
Chlorambucil—Anorexia—Thiotepa—urinary bladder cancer	5.36e-05	0.00151	CcSEcCtD
Chlorambucil—Anaemia—Gemcitabine—urinary bladder cancer	5.36e-05	0.00151	CcSEcCtD
Chlorambucil—GSTP1—Cellular responses to stress—GPX1—urinary bladder cancer	5.35e-05	0.00417	CbGpPWpGaD
Chlorambucil—Renal failure acute—Methotrexate—urinary bladder cancer	5.33e-05	0.0015	CcSEcCtD
Chlorambucil—Mouth ulceration—Doxorubicin—urinary bladder cancer	5.31e-05	0.00149	CcSEcCtD
Chlorambucil—Neoplasm—Doxorubicin—urinary bladder cancer	5.31e-05	0.00149	CcSEcCtD
Chlorambucil—Bladder pain—Doxorubicin—urinary bladder cancer	5.31e-05	0.00149	CcSEcCtD
Chlorambucil—Anaemia—Fluorouracil—urinary bladder cancer	5.27e-05	0.00148	CcSEcCtD
Chlorambucil—GSTP1—Metabolism—GSTZ1—urinary bladder cancer	5.25e-05	0.00409	CbGpPWpGaD
Chlorambucil—Leukopenia—Gemcitabine—urinary bladder cancer	5.19e-05	0.00146	CcSEcCtD
Chlorambucil—Leukopenia—Fluorouracil—urinary bladder cancer	5.1e-05	0.00143	CcSEcCtD
Chlorambucil—Tremor—Cisplatin—urinary bladder cancer	5.06e-05	0.00142	CcSEcCtD
Chlorambucil—Alopecia—Etoposide—urinary bladder cancer	5.02e-05	0.00141	CcSEcCtD
Chlorambucil—Lymphadenopathy—Doxorubicin—urinary bladder cancer	5e-05	0.0014	CcSEcCtD
Chlorambucil—Anaemia—Cisplatin—urinary bladder cancer	4.99e-05	0.0014	CcSEcCtD
Chlorambucil—Renal failure acute—Epirubicin—urinary bladder cancer	4.99e-05	0.0014	CcSEcCtD
Chlorambucil—GSTP1—Metabolism—GSTO2—urinary bladder cancer	4.97e-05	0.00388	CbGpPWpGaD
Chlorambucil—GSTP1—Metabolism—NAT1—urinary bladder cancer	4.97e-05	0.00388	CbGpPWpGaD
Chlorambucil—Dyspepsia—Thiotepa—urinary bladder cancer	4.95e-05	0.00139	CcSEcCtD
Chlorambucil—SLCO1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	4.95e-05	0.00386	CbGpPWpGaD
Chlorambucil—Convulsion—Fluorouracil—urinary bladder cancer	4.94e-05	0.00139	CcSEcCtD
Chlorambucil—Decreased appetite—Thiotepa—urinary bladder cancer	4.89e-05	0.00137	CcSEcCtD
Chlorambucil—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	4.85e-05	0.00136	CcSEcCtD
Chlorambucil—Fatigue—Thiotepa—urinary bladder cancer	4.85e-05	0.00136	CcSEcCtD
Chlorambucil—Leukopenia—Cisplatin—urinary bladder cancer	4.83e-05	0.00136	CcSEcCtD
Chlorambucil—Pain—Thiotepa—urinary bladder cancer	4.81e-05	0.00135	CcSEcCtD
Chlorambucil—Infection—Gemcitabine—urinary bladder cancer	4.7e-05	0.00132	CcSEcCtD
Chlorambucil—Confusional state—Fluorouracil—urinary bladder cancer	4.69e-05	0.00132	CcSEcCtD
Chlorambucil—Convulsion—Cisplatin—urinary bladder cancer	4.68e-05	0.00132	CcSEcCtD
Chlorambucil—Feeling abnormal—Thiotepa—urinary bladder cancer	4.63e-05	0.0013	CcSEcCtD
Chlorambucil—Thrombocytopenia—Gemcitabine—urinary bladder cancer	4.63e-05	0.0013	CcSEcCtD
Chlorambucil—Ataxia—Methotrexate—urinary bladder cancer	4.63e-05	0.0013	CcSEcCtD
Chlorambucil—Infection—Fluorouracil—urinary bladder cancer	4.62e-05	0.0013	CcSEcCtD
Chlorambucil—Renal failure acute—Doxorubicin—urinary bladder cancer	4.62e-05	0.0013	CcSEcCtD
Chlorambucil—Gastrointestinal pain—Thiotepa—urinary bladder cancer	4.6e-05	0.00129	CcSEcCtD
Chlorambucil—Anaemia—Etoposide—urinary bladder cancer	4.57e-05	0.00129	CcSEcCtD
Chlorambucil—Thrombocytopenia—Fluorouracil—urinary bladder cancer	4.55e-05	0.00128	CcSEcCtD
Chlorambucil—GSTP1—Metabolism—UGT2B7—urinary bladder cancer	4.55e-05	0.00355	CbGpPWpGaD
Chlorambucil—Anorexia—Gemcitabine—urinary bladder cancer	4.51e-05	0.00127	CcSEcCtD
Chlorambucil—Urticaria—Thiotepa—urinary bladder cancer	4.47e-05	0.00126	CcSEcCtD
Chlorambucil—Abdominal pain—Thiotepa—urinary bladder cancer	4.44e-05	0.00125	CcSEcCtD
Chlorambucil—Body temperature increased—Thiotepa—urinary bladder cancer	4.44e-05	0.00125	CcSEcCtD
Chlorambucil—Anorexia—Fluorouracil—urinary bladder cancer	4.43e-05	0.00125	CcSEcCtD
Chlorambucil—Toxic epidermal necrolysis—Methotrexate—urinary bladder cancer	4.43e-05	0.00125	CcSEcCtD
Chlorambucil—Leukopenia—Etoposide—urinary bladder cancer	4.43e-05	0.00125	CcSEcCtD
Chlorambucil—GSTP1—Cellular responses to stress—ATM—urinary bladder cancer	4.42e-05	0.00345	CbGpPWpGaD
Chlorambucil—GSTP1—Cellular responses to stress—CDK4—urinary bladder cancer	4.41e-05	0.00344	CbGpPWpGaD
Chlorambucil—Infection—Cisplatin—urinary bladder cancer	4.38e-05	0.00123	CcSEcCtD
Chlorambucil—Ataxia—Epirubicin—urinary bladder cancer	4.33e-05	0.00122	CcSEcCtD
Chlorambucil—Thrombocytopenia—Cisplatin—urinary bladder cancer	4.32e-05	0.00121	CcSEcCtD
Chlorambucil—Convulsion—Etoposide—urinary bladder cancer	4.29e-05	0.00121	CcSEcCtD
Chlorambucil—Anorexia—Cisplatin—urinary bladder cancer	4.2e-05	0.00118	CcSEcCtD
Chlorambucil—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	4.15e-05	0.00117	CcSEcCtD
Chlorambucil—Hypersensitivity—Thiotepa—urinary bladder cancer	4.14e-05	0.00116	CcSEcCtD
Chlorambucil—SLCO1A2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	4.13e-05	0.00322	CbGpPWpGaD
Chlorambucil—Decreased appetite—Gemcitabine—urinary bladder cancer	4.11e-05	0.00116	CcSEcCtD
Chlorambucil—GSTP1—Metabolism—CYP4B1—urinary bladder cancer	4.09e-05	0.00319	CbGpPWpGaD
Chlorambucil—Dyspepsia—Fluorouracil—urinary bladder cancer	4.09e-05	0.00115	CcSEcCtD
Chlorambucil—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	4.08e-05	0.00115	CcSEcCtD
Chlorambucil—Fatigue—Gemcitabine—urinary bladder cancer	4.08e-05	0.00115	CcSEcCtD
Chlorambucil—Confusional state—Etoposide—urinary bladder cancer	4.07e-05	0.00114	CcSEcCtD
Chlorambucil—Pain—Gemcitabine—urinary bladder cancer	4.04e-05	0.00114	CcSEcCtD
Chlorambucil—Decreased appetite—Fluorouracil—urinary bladder cancer	4.04e-05	0.00114	CcSEcCtD
Chlorambucil—Pancytopenia—Methotrexate—urinary bladder cancer	4.04e-05	0.00114	CcSEcCtD
Chlorambucil—Asthenia—Thiotepa—urinary bladder cancer	4.03e-05	0.00113	CcSEcCtD
Chlorambucil—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	4.01e-05	0.00113	CcSEcCtD
Chlorambucil—Infection—Etoposide—urinary bladder cancer	4.01e-05	0.00113	CcSEcCtD
Chlorambucil—Ataxia—Doxorubicin—urinary bladder cancer	4.01e-05	0.00113	CcSEcCtD
Chlorambucil—Neutropenia—Methotrexate—urinary bladder cancer	3.98e-05	0.00112	CcSEcCtD
Chlorambucil—Pruritus—Thiotepa—urinary bladder cancer	3.98e-05	0.00112	CcSEcCtD
Chlorambucil—Pain—Fluorouracil—urinary bladder cancer	3.98e-05	0.00112	CcSEcCtD
Chlorambucil—Thrombocytopenia—Etoposide—urinary bladder cancer	3.95e-05	0.00111	CcSEcCtD
Chlorambucil—Feeling abnormal—Gemcitabine—urinary bladder cancer	3.9e-05	0.0011	CcSEcCtD
Chlorambucil—GSTP1—Metabolism—SLC19A1—urinary bladder cancer	3.87e-05	0.00302	CbGpPWpGaD
Chlorambucil—Anorexia—Etoposide—urinary bladder cancer	3.85e-05	0.00108	CcSEcCtD
Chlorambucil—Diarrhoea—Thiotepa—urinary bladder cancer	3.85e-05	0.00108	CcSEcCtD
Chlorambucil—GSTP1—Cellular responses to stress—CREBBP—urinary bladder cancer	3.84e-05	0.003	CbGpPWpGaD
Chlorambucil—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	3.84e-05	0.00108	CcSEcCtD
Chlorambucil—Decreased appetite—Cisplatin—urinary bladder cancer	3.83e-05	0.00108	CcSEcCtD
Chlorambucil—Feeling abnormal—Fluorouracil—urinary bladder cancer	3.83e-05	0.00108	CcSEcCtD
Chlorambucil—GSTP1—Cellular responses to stress—RB1—urinary bladder cancer	3.83e-05	0.00299	CbGpPWpGaD
Chlorambucil—Pneumonia—Methotrexate—urinary bladder cancer	3.81e-05	0.00107	CcSEcCtD
Chlorambucil—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	3.81e-05	0.00107	CcSEcCtD
Chlorambucil—Pancytopenia—Epirubicin—urinary bladder cancer	3.78e-05	0.00106	CcSEcCtD
Chlorambucil—Pain—Cisplatin—urinary bladder cancer	3.77e-05	0.00106	CcSEcCtD
Chlorambucil—GSTP1—Metabolism—PRSS3—urinary bladder cancer	3.77e-05	0.00294	CbGpPWpGaD
Chlorambucil—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	3.76e-05	0.00106	CcSEcCtD
Chlorambucil—Body temperature increased—Gemcitabine—urinary bladder cancer	3.74e-05	0.00105	CcSEcCtD
Chlorambucil—Neutropenia—Epirubicin—urinary bladder cancer	3.72e-05	0.00105	CcSEcCtD
Chlorambucil—Stomatitis—Methotrexate—urinary bladder cancer	3.7e-05	0.00104	CcSEcCtD
Chlorambucil—Urticaria—Fluorouracil—urinary bladder cancer	3.69e-05	0.00104	CcSEcCtD
Chlorambucil—Body temperature increased—Fluorouracil—urinary bladder cancer	3.68e-05	0.00103	CcSEcCtD
Chlorambucil—Feeling abnormal—Cisplatin—urinary bladder cancer	3.63e-05	0.00102	CcSEcCtD
Chlorambucil—Vomiting—Thiotepa—urinary bladder cancer	3.57e-05	0.001	CcSEcCtD
Chlorambucil—Pneumonia—Epirubicin—urinary bladder cancer	3.57e-05	0.001	CcSEcCtD
Chlorambucil—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	3.52e-05	0.000989	CcSEcCtD
Chlorambucil—Decreased appetite—Etoposide—urinary bladder cancer	3.51e-05	0.000987	CcSEcCtD
Chlorambucil—Pancytopenia—Doxorubicin—urinary bladder cancer	3.5e-05	0.000983	CcSEcCtD
Chlorambucil—Gastrointestinal disorder—Etoposide—urinary bladder cancer	3.49e-05	0.00098	CcSEcCtD
Chlorambucil—Body temperature increased—Cisplatin—urinary bladder cancer	3.48e-05	0.00098	CcSEcCtD
Chlorambucil—Fatigue—Etoposide—urinary bladder cancer	3.48e-05	0.000979	CcSEcCtD
Chlorambucil—Neuropathy peripheral—Epirubicin—urinary bladder cancer	3.48e-05	0.000978	CcSEcCtD
Chlorambucil—Stomatitis—Epirubicin—urinary bladder cancer	3.46e-05	0.000973	CcSEcCtD
Chlorambucil—Jaundice—Epirubicin—urinary bladder cancer	3.46e-05	0.000973	CcSEcCtD
Chlorambucil—Pain—Etoposide—urinary bladder cancer	3.45e-05	0.000971	CcSEcCtD
Chlorambucil—Neutropenia—Doxorubicin—urinary bladder cancer	3.44e-05	0.000968	CcSEcCtD
Chlorambucil—Hypersensitivity—Fluorouracil—urinary bladder cancer	3.43e-05	0.000963	CcSEcCtD
Chlorambucil—Asthenia—Gemcitabine—urinary bladder cancer	3.39e-05	0.000954	CcSEcCtD
Chlorambucil—GSTP1—Cellular responses to stress—CDKN2A—urinary bladder cancer	3.37e-05	0.00263	CbGpPWpGaD
Chlorambucil—SLCO1A2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	3.37e-05	0.00263	CbGpPWpGaD
Chlorambucil—Pruritus—Gemcitabine—urinary bladder cancer	3.35e-05	0.000941	CcSEcCtD
Chlorambucil—Nausea—Thiotepa—urinary bladder cancer	3.34e-05	0.000939	CcSEcCtD
Chlorambucil—Feeling abnormal—Etoposide—urinary bladder cancer	3.33e-05	0.000936	CcSEcCtD
Chlorambucil—Pneumonia—Doxorubicin—urinary bladder cancer	3.3e-05	0.000929	CcSEcCtD
Chlorambucil—Gastrointestinal pain—Etoposide—urinary bladder cancer	3.3e-05	0.000928	CcSEcCtD
Chlorambucil—Pruritus—Fluorouracil—urinary bladder cancer	3.29e-05	0.000925	CcSEcCtD
Chlorambucil—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	3.26e-05	0.000915	CcSEcCtD
Chlorambucil—Hypersensitivity—Cisplatin—urinary bladder cancer	3.25e-05	0.000913	CcSEcCtD
Chlorambucil—Diarrhoea—Gemcitabine—urinary bladder cancer	3.24e-05	0.00091	CcSEcCtD
Chlorambucil—Erythema multiforme—Methotrexate—urinary bladder cancer	3.22e-05	0.000905	CcSEcCtD
Chlorambucil—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	3.22e-05	0.000905	CcSEcCtD
Chlorambucil—Urticaria—Etoposide—urinary bladder cancer	3.21e-05	0.000902	CcSEcCtD
Chlorambucil—Stomatitis—Doxorubicin—urinary bladder cancer	3.2e-05	0.0009	CcSEcCtD
Chlorambucil—Jaundice—Doxorubicin—urinary bladder cancer	3.2e-05	0.0009	CcSEcCtD
Chlorambucil—Abdominal pain—Etoposide—urinary bladder cancer	3.19e-05	0.000897	CcSEcCtD
Chlorambucil—Body temperature increased—Etoposide—urinary bladder cancer	3.19e-05	0.000897	CcSEcCtD
Chlorambucil—Diarrhoea—Fluorouracil—urinary bladder cancer	3.18e-05	0.000894	CcSEcCtD
Chlorambucil—Asthenia—Cisplatin—urinary bladder cancer	3.16e-05	0.000889	CcSEcCtD
Chlorambucil—GSTP1—Cellular responses to stress—CXCL8—urinary bladder cancer	3.05e-05	0.00238	CbGpPWpGaD
Chlorambucil—Diarrhoea—Cisplatin—urinary bladder cancer	3.02e-05	0.000848	CcSEcCtD
Chlorambucil—Erythema multiforme—Epirubicin—urinary bladder cancer	3.01e-05	0.000847	CcSEcCtD
Chlorambucil—GSTP1—Metabolism—TYMP—urinary bladder cancer	3.01e-05	0.00235	CbGpPWpGaD
Chlorambucil—Alopecia—Methotrexate—urinary bladder cancer	3.01e-05	0.000846	CcSEcCtD
Chlorambucil—Vomiting—Gemcitabine—urinary bladder cancer	3.01e-05	0.000845	CcSEcCtD
Chlorambucil—Hypersensitivity—Etoposide—urinary bladder cancer	2.98e-05	0.000836	CcSEcCtD
Chlorambucil—Vomiting—Fluorouracil—urinary bladder cancer	2.96e-05	0.000831	CcSEcCtD
Chlorambucil—Asthenia—Etoposide—urinary bladder cancer	2.9e-05	0.000815	CcSEcCtD
Chlorambucil—Pruritus—Etoposide—urinary bladder cancer	2.86e-05	0.000803	CcSEcCtD
Chlorambucil—SLCO1A2—Metabolism—GSTZ1—urinary bladder cancer	2.82e-05	0.0022	CbGpPWpGaD
Chlorambucil—Alopecia—Epirubicin—urinary bladder cancer	2.82e-05	0.000792	CcSEcCtD
Chlorambucil—Nausea—Gemcitabine—urinary bladder cancer	2.81e-05	0.00079	CcSEcCtD
Chlorambucil—Vomiting—Cisplatin—urinary bladder cancer	2.8e-05	0.000788	CcSEcCtD
Chlorambucil—Erythema multiforme—Doxorubicin—urinary bladder cancer	2.79e-05	0.000784	CcSEcCtD
Chlorambucil—Diarrhoea—Etoposide—urinary bladder cancer	2.76e-05	0.000777	CcSEcCtD
Chlorambucil—Nausea—Fluorouracil—urinary bladder cancer	2.76e-05	0.000776	CcSEcCtD
Chlorambucil—GSTP1—Cellular responses to stress—CDKN1A—urinary bladder cancer	2.75e-05	0.00215	CbGpPWpGaD
Chlorambucil—Anaemia—Methotrexate—urinary bladder cancer	2.74e-05	0.00077	CcSEcCtD
Chlorambucil—GSTP1—Metabolism—NAT2—urinary bladder cancer	2.72e-05	0.00212	CbGpPWpGaD
Chlorambucil—SLCO1A2—Metabolism—GSTO2—urinary bladder cancer	2.67e-05	0.00209	CbGpPWpGaD
Chlorambucil—SLCO1A2—Metabolism—NAT1—urinary bladder cancer	2.67e-05	0.00209	CbGpPWpGaD
Chlorambucil—Leukopenia—Methotrexate—urinary bladder cancer	2.65e-05	0.000746	CcSEcCtD
Chlorambucil—SLCO1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	2.63e-05	0.00205	CbGpPWpGaD
Chlorambucil—GSTP1—Cellular responses to stress—EP300—urinary bladder cancer	2.62e-05	0.00204	CbGpPWpGaD
Chlorambucil—Nausea—Cisplatin—urinary bladder cancer	2.62e-05	0.000736	CcSEcCtD
Chlorambucil—Alopecia—Doxorubicin—urinary bladder cancer	2.61e-05	0.000732	CcSEcCtD
Chlorambucil—Convulsion—Methotrexate—urinary bladder cancer	2.57e-05	0.000722	CcSEcCtD
Chlorambucil—Vomiting—Etoposide—urinary bladder cancer	2.57e-05	0.000722	CcSEcCtD
Chlorambucil—Anaemia—Epirubicin—urinary bladder cancer	2.56e-05	0.000721	CcSEcCtD
Chlorambucil—Agitation—Epirubicin—urinary bladder cancer	2.55e-05	0.000717	CcSEcCtD
Chlorambucil—Leukopenia—Epirubicin—urinary bladder cancer	2.48e-05	0.000698	CcSEcCtD
Chlorambucil—SLCO1A2—Metabolism—UGT2B7—urinary bladder cancer	2.45e-05	0.00191	CbGpPWpGaD
Chlorambucil—Confusional state—Methotrexate—urinary bladder cancer	2.44e-05	0.000686	CcSEcCtD
Chlorambucil—Convulsion—Epirubicin—urinary bladder cancer	2.4e-05	0.000676	CcSEcCtD
Chlorambucil—Infection—Methotrexate—urinary bladder cancer	2.4e-05	0.000676	CcSEcCtD
Chlorambucil—Nausea—Etoposide—urinary bladder cancer	2.4e-05	0.000674	CcSEcCtD
Chlorambucil—Anaemia—Doxorubicin—urinary bladder cancer	2.37e-05	0.000667	CcSEcCtD
Chlorambucil—Thrombocytopenia—Methotrexate—urinary bladder cancer	2.37e-05	0.000666	CcSEcCtD
Chlorambucil—Agitation—Doxorubicin—urinary bladder cancer	2.36e-05	0.000663	CcSEcCtD
Chlorambucil—GSTP1—Metabolism—RRM2—urinary bladder cancer	2.35e-05	0.00183	CbGpPWpGaD
Chlorambucil—Anorexia—Methotrexate—urinary bladder cancer	2.31e-05	0.000648	CcSEcCtD
Chlorambucil—Leukopenia—Doxorubicin—urinary bladder cancer	2.3e-05	0.000646	CcSEcCtD
Chlorambucil—Confusional state—Epirubicin—urinary bladder cancer	2.28e-05	0.000642	CcSEcCtD
Chlorambucil—SLCO1A2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	2.27e-05	0.00177	CbGpPWpGaD
Chlorambucil—Infection—Epirubicin—urinary bladder cancer	2.25e-05	0.000632	CcSEcCtD
Chlorambucil—Convulsion—Doxorubicin—urinary bladder cancer	2.22e-05	0.000625	CcSEcCtD
Chlorambucil—Thrombocytopenia—Epirubicin—urinary bladder cancer	2.22e-05	0.000623	CcSEcCtD
Chlorambucil—SLCO1A2—Metabolism—CYP4B1—urinary bladder cancer	2.2e-05	0.00172	CbGpPWpGaD
Chlorambucil—GSTP1—Metabolism—ENO2—urinary bladder cancer	2.18e-05	0.0017	CbGpPWpGaD
Chlorambucil—GSTP1—Metabolism—HPGDS—urinary bladder cancer	2.18e-05	0.0017	CbGpPWpGaD
Chlorambucil—Anorexia—Epirubicin—urinary bladder cancer	2.16e-05	0.000607	CcSEcCtD
Chlorambucil—Dyspepsia—Methotrexate—urinary bladder cancer	2.13e-05	0.000599	CcSEcCtD
Chlorambucil—GSTP1—Metabolism—GSTT1—urinary bladder cancer	2.11e-05	0.00165	CbGpPWpGaD
Chlorambucil—Confusional state—Doxorubicin—urinary bladder cancer	2.11e-05	0.000594	CcSEcCtD
Chlorambucil—Decreased appetite—Methotrexate—urinary bladder cancer	2.1e-05	0.000591	CcSEcCtD
Chlorambucil—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	2.09e-05	0.000587	CcSEcCtD
Chlorambucil—Fatigue—Methotrexate—urinary bladder cancer	2.09e-05	0.000586	CcSEcCtD
Chlorambucil—Infection—Doxorubicin—urinary bladder cancer	2.08e-05	0.000585	CcSEcCtD
Chlorambucil—SLCO1A2—Metabolism—SLC19A1—urinary bladder cancer	2.08e-05	0.00162	CbGpPWpGaD
Chlorambucil—Pain—Methotrexate—urinary bladder cancer	2.07e-05	0.000581	CcSEcCtD
Chlorambucil—Thrombocytopenia—Doxorubicin—urinary bladder cancer	2.05e-05	0.000577	CcSEcCtD
Chlorambucil—SLCO1A2—Metabolism—PRSS3—urinary bladder cancer	2.03e-05	0.00158	CbGpPWpGaD
Chlorambucil—Anorexia—Doxorubicin—urinary bladder cancer	2e-05	0.000561	CcSEcCtD
Chlorambucil—Feeling abnormal—Methotrexate—urinary bladder cancer	1.99e-05	0.00056	CcSEcCtD
Chlorambucil—Dyspepsia—Epirubicin—urinary bladder cancer	1.99e-05	0.00056	CcSEcCtD
Chlorambucil—Gastrointestinal pain—Methotrexate—urinary bladder cancer	1.98e-05	0.000556	CcSEcCtD
Chlorambucil—Decreased appetite—Epirubicin—urinary bladder cancer	1.97e-05	0.000553	CcSEcCtD
Chlorambucil—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	1.95e-05	0.000549	CcSEcCtD
Chlorambucil—Fatigue—Epirubicin—urinary bladder cancer	1.95e-05	0.000549	CcSEcCtD
Chlorambucil—Pain—Epirubicin—urinary bladder cancer	1.94e-05	0.000544	CcSEcCtD
Chlorambucil—Urticaria—Methotrexate—urinary bladder cancer	1.92e-05	0.00054	CcSEcCtD
Chlorambucil—Body temperature increased—Methotrexate—urinary bladder cancer	1.91e-05	0.000538	CcSEcCtD
Chlorambucil—Abdominal pain—Methotrexate—urinary bladder cancer	1.91e-05	0.000538	CcSEcCtD
Chlorambucil—GSTP1—Cellular responses to stress—TP53—urinary bladder cancer	1.87e-05	0.00146	CbGpPWpGaD
Chlorambucil—Feeling abnormal—Epirubicin—urinary bladder cancer	1.87e-05	0.000524	CcSEcCtD
Chlorambucil—Gastrointestinal pain—Epirubicin—urinary bladder cancer	1.85e-05	0.00052	CcSEcCtD
Chlorambucil—Dyspepsia—Doxorubicin—urinary bladder cancer	1.84e-05	0.000518	CcSEcCtD
Chlorambucil—Decreased appetite—Doxorubicin—urinary bladder cancer	1.82e-05	0.000512	CcSEcCtD
Chlorambucil—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	1.81e-05	0.000508	CcSEcCtD
Chlorambucil—Fatigue—Doxorubicin—urinary bladder cancer	1.81e-05	0.000508	CcSEcCtD
Chlorambucil—Urticaria—Epirubicin—urinary bladder cancer	1.8e-05	0.000506	CcSEcCtD
Chlorambucil—Pain—Doxorubicin—urinary bladder cancer	1.79e-05	0.000504	CcSEcCtD
Chlorambucil—Body temperature increased—Epirubicin—urinary bladder cancer	1.79e-05	0.000503	CcSEcCtD
Chlorambucil—Abdominal pain—Epirubicin—urinary bladder cancer	1.79e-05	0.000503	CcSEcCtD
Chlorambucil—Hypersensitivity—Methotrexate—urinary bladder cancer	1.78e-05	0.000501	CcSEcCtD
Chlorambucil—GSTP1—Metabolism—NQO1—urinary bladder cancer	1.76e-05	0.00137	CbGpPWpGaD
Chlorambucil—Asthenia—Methotrexate—urinary bladder cancer	1.74e-05	0.000488	CcSEcCtD
Chlorambucil—Feeling abnormal—Doxorubicin—urinary bladder cancer	1.73e-05	0.000485	CcSEcCtD
Chlorambucil—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	1.71e-05	0.000481	CcSEcCtD
Chlorambucil—Pruritus—Methotrexate—urinary bladder cancer	1.71e-05	0.000481	CcSEcCtD
Chlorambucil—Hypersensitivity—Epirubicin—urinary bladder cancer	1.67e-05	0.000469	CcSEcCtD
Chlorambucil—Urticaria—Doxorubicin—urinary bladder cancer	1.66e-05	0.000468	CcSEcCtD
Chlorambucil—Body temperature increased—Doxorubicin—urinary bladder cancer	1.66e-05	0.000465	CcSEcCtD
Chlorambucil—Abdominal pain—Doxorubicin—urinary bladder cancer	1.66e-05	0.000465	CcSEcCtD
Chlorambucil—Diarrhoea—Methotrexate—urinary bladder cancer	1.66e-05	0.000465	CcSEcCtD
Chlorambucil—SLCO1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.63e-05	0.00127	CbGpPWpGaD
Chlorambucil—Asthenia—Epirubicin—urinary bladder cancer	1.62e-05	0.000457	CcSEcCtD
Chlorambucil—SLCO1A2—Metabolism—TYMP—urinary bladder cancer	1.62e-05	0.00126	CbGpPWpGaD
Chlorambucil—Pruritus—Epirubicin—urinary bladder cancer	1.6e-05	0.00045	CcSEcCtD
Chlorambucil—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.56e-05	0.00121	CbGpPWpGaD
Chlorambucil—Diarrhoea—Epirubicin—urinary bladder cancer	1.55e-05	0.000435	CcSEcCtD
Chlorambucil—Hypersensitivity—Doxorubicin—urinary bladder cancer	1.54e-05	0.000434	CcSEcCtD
Chlorambucil—Vomiting—Methotrexate—urinary bladder cancer	1.54e-05	0.000432	CcSEcCtD
Chlorambucil—Asthenia—Doxorubicin—urinary bladder cancer	1.5e-05	0.000422	CcSEcCtD
Chlorambucil—Pruritus—Doxorubicin—urinary bladder cancer	1.48e-05	0.000417	CcSEcCtD
Chlorambucil—SLCO1A2—Metabolism—NAT2—urinary bladder cancer	1.47e-05	0.00114	CbGpPWpGaD
Chlorambucil—Vomiting—Epirubicin—urinary bladder cancer	1.44e-05	0.000405	CcSEcCtD
Chlorambucil—Nausea—Methotrexate—urinary bladder cancer	1.44e-05	0.000404	CcSEcCtD
Chlorambucil—Diarrhoea—Doxorubicin—urinary bladder cancer	1.43e-05	0.000403	CcSEcCtD
Chlorambucil—GSTP1—Metabolism—TYMS—urinary bladder cancer	1.36e-05	0.00106	CbGpPWpGaD
Chlorambucil—GSTP1—Metabolism—GSTM1—urinary bladder cancer	1.35e-05	0.00105	CbGpPWpGaD
Chlorambucil—GSTP1—Metabolism—NCOR1—urinary bladder cancer	1.35e-05	0.00105	CbGpPWpGaD
Chlorambucil—Nausea—Epirubicin—urinary bladder cancer	1.34e-05	0.000378	CcSEcCtD
Chlorambucil—Vomiting—Doxorubicin—urinary bladder cancer	1.33e-05	0.000374	CcSEcCtD
Chlorambucil—GSTP1—Metabolism—GPX1—urinary bladder cancer	1.29e-05	0.00101	CbGpPWpGaD
Chlorambucil—SLCO1A2—Metabolism—RRM2—urinary bladder cancer	1.27e-05	0.000987	CbGpPWpGaD
Chlorambucil—GSTP1—Metabolism—ERCC2—urinary bladder cancer	1.27e-05	0.000987	CbGpPWpGaD
Chlorambucil—Nausea—Doxorubicin—urinary bladder cancer	1.24e-05	0.00035	CcSEcCtD
Chlorambucil—GSTP1—Metabolism—MTHFR—urinary bladder cancer	1.19e-05	0.000928	CbGpPWpGaD
Chlorambucil—SLCO1A2—Metabolism—ENO2—urinary bladder cancer	1.17e-05	0.000914	CbGpPWpGaD
Chlorambucil—SLCO1A2—Metabolism—HPGDS—urinary bladder cancer	1.17e-05	0.000914	CbGpPWpGaD
Chlorambucil—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.16e-05	0.000909	CbGpPWpGaD
Chlorambucil—SLCO1A2—Metabolism—GSTT1—urinary bladder cancer	1.14e-05	0.000886	CbGpPWpGaD
Chlorambucil—SLCO1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.12e-05	0.000873	CbGpPWpGaD
Chlorambucil—SLCO1A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.06e-05	0.00083	CbGpPWpGaD
Chlorambucil—GSTP1—Metabolism—PPARG—urinary bladder cancer	9.64e-06	0.000752	CbGpPWpGaD
Chlorambucil—SLCO1A2—Metabolism—NQO1—urinary bladder cancer	9.44e-06	0.000737	CbGpPWpGaD
Chlorambucil—GSTP1—Metabolism—CREBBP—urinary bladder cancer	9.26e-06	0.000723	CbGpPWpGaD
Chlorambucil—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	9.16e-06	0.000715	CbGpPWpGaD
Chlorambucil—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	7.99e-06	0.000623	CbGpPWpGaD
Chlorambucil—SLCO1A2—Metabolism—GSTP1—urinary bladder cancer	7.88e-06	0.000614	CbGpPWpGaD
Chlorambucil—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	7.62e-06	0.000594	CbGpPWpGaD
Chlorambucil—GSTP1—Metabolism—PTGS2—urinary bladder cancer	7.59e-06	0.000592	CbGpPWpGaD
Chlorambucil—SLCO1A2—Metabolism—TYMS—urinary bladder cancer	7.32e-06	0.000571	CbGpPWpGaD
Chlorambucil—SLCO1A2—Metabolism—GSTM1—urinary bladder cancer	7.24e-06	0.000565	CbGpPWpGaD
Chlorambucil—SLCO1A2—Metabolism—NCOR1—urinary bladder cancer	7.24e-06	0.000565	CbGpPWpGaD
Chlorambucil—SLCO1A2—Metabolism—GPX1—urinary bladder cancer	6.93e-06	0.000541	CbGpPWpGaD
Chlorambucil—SLCO1A2—Metabolism—ERCC2—urinary bladder cancer	6.81e-06	0.000531	CbGpPWpGaD
Chlorambucil—GSTP1—Metabolism—PTEN—urinary bladder cancer	6.62e-06	0.000516	CbGpPWpGaD
Chlorambucil—SLCO1A2—Metabolism—MTHFR—urinary bladder cancer	6.4e-06	0.000499	CbGpPWpGaD
Chlorambucil—GSTP1—Metabolism—EP300—urinary bladder cancer	6.31e-06	0.000492	CbGpPWpGaD
Chlorambucil—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	5.19e-06	0.000405	CbGpPWpGaD
Chlorambucil—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	4.98e-06	0.000389	CbGpPWpGaD
Chlorambucil—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	4.08e-06	0.000318	CbGpPWpGaD
Chlorambucil—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	3.56e-06	0.000278	CbGpPWpGaD
Chlorambucil—SLCO1A2—Metabolism—EP300—urinary bladder cancer	3.39e-06	0.000265	CbGpPWpGaD
